Remove terms-and-conditions
article thumbnail

With Vtama's success in relieving itching, Dermavant eyes FDA filing in atopic dermatitis

Fierce Pharma

In the race to develop nonsteroidal topical treatments for autoimmune skin conditions, Dermavant is charging toward the finish line—again. Dermavant has presented evidence that Vtama provides immediate and long-term relief from the severe itch condition pruritus, the most prevalent symptom of atopic dermatitis.

FDA 230
article thumbnail

AbbVie breaks ground on new R&D centre

European Pharmaceutical Review

Additionally, flexible working conditions will “enable greater scientific exchange between different areas of research and implement automation and digital research capabilities”, AbbVie shared. The central research building LUdwighafens neue Arbeitswelt (LUnA) will benefit from an investment of approximately €150 million.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Lonza to acquire major biologics manufacturing facility

European Pharmaceutical Review

Lonza stated that with committed volumes over the medium term, this will be phased out as the facility shifts to accommodate alternative customers. Additionally, under the terms of the deal, approximately 750 Genentech employees at the Vacaville (US) facility will be offered employment by Lonza.

article thumbnail

Capsule formulation: future trends

European Pharmaceutical Review

Gelatine also poses potential long-term performance challenges” Several major trends have emerged in recent years in the capsule space. For example, there have been capsules created that allow for monitoring of external conditions, such as pH, and that enable external control over drug release.

article thumbnail

10 Trends for online health seekers

World of DTC Marketing

Here is what I learned: 1ne: Since more people are working at home, they have more time to research health conditions and possible treatments. 9ine: Searches for specific medical terms have increased, indicating that people don’t necessarily understand common medical terms. 2020 trend concept.

Media 287
article thumbnail

Could small molecule medicine treat rare liver disease?

European Pharmaceutical Review

It has a good safety profile and was well- tolerated, and could provide an important new therapeutic option for long-term treatment of patients with this debilitating condition,” stated Howard Mayer, Executive Vice President and Head of Research and Development for Ipsen. There are 22.27

article thumbnail

UK digital health project aims to tackle dysfunctional breathing

pharmaphorum

It would provide an alternative to standard breathing exercises for patients with conditions that affect breathing, including long-term respiratory diseases like asthma, chronic obstructive pulmonary disorder (COPD) and cystic fibrosis, which can be resource-intensive as they require patients to be overseen by a healthcare worker.

Patients 140